Table 3.
Clinical characteristics of diabetic CLD patients and diabetic patients without CLD
| DM without CLD | Diabetic CLD | p value* | ||
|---|---|---|---|---|
| No. of patients | 345 | 40 | ||
| Age (years) | 60 (15–87) | 65 (53–77) | ns | |
| Gender (male/female) | 155/190 | 27/13 | ns | |
| BMI (kg/m2) | 22.8 (16.2–31.8) | 23.2 (16.9–32.4) | ns | |
| FBS (mg/dl) | 120 (41–303) | 148 (69–225) | ns | |
| HbA1c (%) | 6.7 (4.2–12.0) | 6.8 (4.3–10.8) | ns | |
| HOMA-R | 8.3 (0.72–17.58) | 6.9 (0.88–32.2) | ns | |
| Insulin | 28 (3.1–63.0) | 26 (4.4–110) | ns | |
| TG (mg/dl) | 128 (33–430) | 82 (33–233) | p<0.05 | |
| T-cho (mg/dl) | 195 (127–387) | 141 (70–221) | p<0.001 | |
| PT (%) | 89 (77–96) | 72 (40–100) | p<0.001 | |
| Plt (×104/µl) | 23.8 (12.8–33.4) | 9.9 (2.4–28.6) | p<0.001 | |
| Treatment | ||||
| Diet | 49 (14%) | 10 (25%) | ||
| Drug | 128 (37%) | 17 (43%) | ns | |
| Insulin | 168 (49%) | 13 (32%) | ||
| Triopathy | 225 (65%) | 12 (30%) | p<0.001 | |
| Retinopathy | 133 (39%) | 8 (20%) | p<0.05 | |
| Neuropathy | 121 (35%) | 8 (20%) | p=0.06 | |
| Nephropathy | 57 (17%) | 4 (10%) | ns |
Values are expressed as median (range).
*
by Mann-Whitney’s U test or chi-square test. Abbreviations used are; DM, diabetes mellitus; CLD, chronic liver disease; BMI, body mass index; FBS, fasting blood sugar; HbA1c, glycosylated hemoglobin; HOMA-R, homeostasis model assessment; Alb, serum albumin; TG, triglyceride; T-cho, total-cholesterol; PT, prothrombin time; Plt, platelet count; ns, not significant.